| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000030375 |
| Receipt No. | R000034677 |
| Official scientific title of the study | Clinical evaluation of intake of collagen peptides in increasing skin moisture content |
| Date of disclosure of the study information | 2017/12/13 |
| Last modified on | 2017/12/13 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | Clinical evaluation of intake of collagen peptides in increasing skin moisture content | |
| Title of the study (Brief title) | Clinical evaluation of intake of collagen peptides in increasing skin moisture content | |
| Region |
|
|
| Condition | |||
| Condition | Healthy subjects | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | Confirmation of improvement skin moisture content after the consumption of a test food in healthy subjects |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Stratum corneum water content at 0, 4, 8, 12 weeks after the intake |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 3 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | Test food (1 g a day for 12 weeks) | |
| Interventions/Control_2 | Test food (5 g a day for 12 weeks) | |
| Interventions/Control_3 | Placebo food (12 weeks) | |
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Female | |||
| Key inclusion criteria | A person who is a healthy person who does not fall under the following exclusion criteria and whose age at the time of consent acquisition date is from 35 years old to under 50 years old and who give written informed consent
1) Individuals who considered that they had dry skin 2) Individual who considered that they had decreased skin elasticity 3) Individuals who agreed to abstain from drinking alcohol from the day before measurement to the end of measurement 4) Individuals who agreed to participate in the study |
|||
| Key exclusion criteria | 1) Individuals who habitually use medicines, collagen-containing supplement, skin supplement, or slimming aid
2) Individuals with skin abnormalities at the sites to be tested 3) Patients with food allergies 4) Individuals who had received cosmetic medical treatment at the sites to be tested 5) Individuals who had received facial treatment within 1 month before the start of the study 6) Individuals with chronic conditions such as atopic dermatitis 7) Patients receiving drug therapy as outpatients 8) Habitual smokers 9) Patients with asthma 10) Individuals taking or intending to take drugs for pollinosis 11) Pregnant woman, woman desiring to become pregnant, or lactating woman 12) Individuals who had participated in other studies within the previous 3 months 13) Subjects who are judged as unsuitable for the study by the investigator for other reason |
|||
| Target sample size | 90 | |||
| Research contact person | |
| Name of lead principal investigator | Masashi Ogo |
| Organization | Siseido Co., Ltd. |
| Division name | Global Innovation Center |
| Address | 2-2-1, Hayabuchi, Tsuzuki-ku, Yokohama, Kanagawa, 224-8558 Japan |
| TEL | 045-590-6000 |
| masashi.ogo@to.shiseido.co.jp | |
| Public contact | |
| Name of contact person | Kazunori Takashima |
| Organization | Inforward, Inc |
| Division name | Ebisu Skin Research Center |
| Address | 1-11-2 Ebisu, Shibuya, Tokyo 1500013, Japan |
| TEL | 03-5447-6411 |
| Homepage URL | |
| takashima@inforward.co.jp | |
| Sponsor | |
| Institute | Siseido Co., Ltd. |
| Institute | |
| Department | |
| Funding Source | |
| Organization | none |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000034677 |